Tags : Vir Biotechnology

Weekly Snapshot

PharmaShots Weekly Snapshot (Oct 5-9, 2020)

Takeda Signs ~$1B Pact with Arrowhead for ARO-AAT Targeting Alpha-1 Antitrypsin-Associated Liver Disease    Published: Oct 9, 2020 | Tags: Alpha-1 Antitrypsin-Associated Liver Disease, Arrowhead, Collaborates, Commercialize. ARO-AAT, Develop, Takeda, with Lilly and Incyte’s Olumiant (baricitinib) Reports Additional Data Demonstrating Reduction in COVID-19 Recovery Time  Published: Oct 9, 2020 | Tags: COVID-19, Demonstrate, Incyte, Lilly, […]Read More

COVID-19 Pharma

Samsung Biologics Signs an Agreement with Vir Biotechnology to Develop

Shots: The total deal value is $362M and under this agreement, Samsung is expected to commence its manufacturing till Oct in Plant 3, with expected commercialization in early 2021. Additionally, the companies will continue to negotiate terms in agreement with expected finalization till Jul 31, 2020 The agreement follows the Vir’s manufacturing collaboration with WuXi […]Read More


Insights+: COVID-19 Healthcare News Updates

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where […]Read More

Weekly Snapshot

PharmaShots Weekly Snapshot (March 23-27, 2020)

1. Mylan Delays its Merger with Upjohn Due to COVID-19 Pandemic Published: Mar 26, 2020 | Tags: Mylan, Delays, Merger, Upjohn, Due, COVID-19 Pandemic 2.  Medopad Provides its Remote Patient Monitoring Platform to Support Global COVID-19 Pandemic2 Published: Mar 26, 2020 | Tags: Medopad, Provides, Remote Patient Monitoring Platform, Support, Global, COVID-19 Pandemic 3.  Quidel’s […]Read More